Trial Profile
A Randomized, Open-label, One Dose, 2-way Crossover Study to Evaluate the Bioequivalence of Elantan SR* 60 mg in Comparison With Imdur SR* 60 mg Under Fasted and Fed Conditions in Healthy Korean Male Subjects (*Sustained Release)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Isosorbide mononitrate (Primary)
- Indications Angina pectoris
- Focus Pharmacokinetics
- Sponsors UCB
- 11 Apr 2014 New trial record